// App-Quantinova.ai

Tu2033 : Investigating the Microbiome Pre and Post Fecal Microbiota Therapy From Active Ulcerative Colitis Patients in a Randomized Placebo Controlled Trial

Researchers

Presenter

  • Fiona J. Whelan

Principal Investigators

  • Paul Moayyedi

  • Christine H. Lee

  • Melanie Wolfe

  • Catherine Onishi

  • John K. Marshall

  • David Armstrong

  • Michael Surette

Medical Centers

  • Division of Urology, McMaster University, Hamilton, ON, Canada

  • Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada

  • Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada

  • Department of Medicine, McMaster University, Hamilton, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

  • Dysbiosis

Biomarkers

  • N/A

Drug/Treatment

  • Roseduria hominis

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved